Sydney, Australia – July 30, 2024 – B. Braun Australia Pty Ltd, a healthcare solutions company is aware of some supply challenges of intravenous (IV) fluids affecting Australian hospitals.

We are conscious of the difficulties this shortage presents concerning the access to IV fluids in our nation. Our teams are exploring available options to assist and are in active discussions with the Therapeutic Goods Administration (TGA) regarding the situation.

B. Braun is committed to maintaining a steady flow of products to our current clientele according to their standard requirements. Any additional or unusual demand from new customers will be considered individually and fulfilled as per our assessment. We aim to give precedence to critical medical applications and to uphold patient care standards.

While specific updates cannot be issued at this current time, we would like to assure everyone that addressing this issue is of utmost importance to us, and information will be disseminated once it's available.

For more information, please contact us